2021
DOI: 10.3390/biom11020195
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetics of Alzheimer’s Disease

Abstract: There are currently no validated biomarkers which can be used to accurately diagnose Alzheimer’s disease (AD) or to distinguish it from other dementia-causing neuropathologies. Moreover, to date, only symptomatic treatments exist for this progressive neurodegenerative disorder. In the search for new, more reliable biomarkers and potential therapeutic options, epigenetic modifications have emerged as important players in the pathogenesis of AD. The aim of the article was to provide a brief overview of the curre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
87
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 82 publications
(92 citation statements)
references
References 283 publications
(179 reference statements)
4
87
0
1
Order By: Relevance
“…Furthermore, from the direct impact of Aβ on mitochondria, some authors also demonstrated that mitochondrial DNA is altered in elderly and AD patients [ 57 ]. Various factors can influence mitochondrial activity, contributing to AD progression.…”
Section: Aβ Vs Oxidative Stressmentioning
confidence: 99%
“…Furthermore, from the direct impact of Aβ on mitochondria, some authors also demonstrated that mitochondrial DNA is altered in elderly and AD patients [ 57 ]. Various factors can influence mitochondrial activity, contributing to AD progression.…”
Section: Aβ Vs Oxidative Stressmentioning
confidence: 99%
“…Although the emergence of Omics technologies has allowed to better characterize epigenetic modifications in the context of AD, these studies, that have been the subject of recent reviews ( Monti et al, 2020 ; Coppedè, 2021 ; Nikolac Perkovic et al, 2021 ), are outside the scope of the present manuscript which is focused on the putative influence of the early environment on AD programming.…”
Section: Epigenetic Mechanisms Mediate Long-term Influence Of Environ...mentioning
confidence: 99%
“…With the progress of population aging, the medical burden of AD patients increases, and AD related research expands rapidly. The etiological theory of AD is gradually getting rid of the simple hypothesis of linear causality proposed by the original amyloid hypothesis, and more and more attention is paid to the important role of epigenetics, aging and lifestyle (16,17), etc. Until now, all the drugs for treating AD can only improve the symptoms of AD, such as slowing the AD patient, etc., and cannot change the pathogenesis of the AD patient to cure AD.…”
Section: Discussionmentioning
confidence: 99%